424. Variability in Tissue Interface Temperature During Pulse Field Atrial Ablation: Implications for Real-Time Contact Assessment.
作者: John R Power.;Keita Watanabe.;Masaya Shinohara.;Fengyuan Yu.;Srinivas Dukkipati.;Daniel R Musikantow.;William Whang.;Joshua Lampert.;Abhishek Maan.;Maryam Saleem.;Ariel Banai.;Connor P Oates.;Sai Krishna Reddy Seemala.;Vivek Y Reddy.;Jacob S Koruth.
来源: Circ Arrhythm Electrophysiol. 2026年19卷5期e014310页
Pulsed field ablation (PFA) can generate low-intensity catheter-tissue interface heating. Recently, a large-focal PFA catheter able to measure the tip-tissue interface temperature has become available. Accordingly, we aimed to characterize the electrode tip-tissue interface temperature dynamics during PFA.
425. JNK2 Is a Stress Integrator Driving Atrial Fibrillation Pathogenesis in Aging via Gut-Heart Crosstalk.
作者: Jiajie Yan.;Elena Carrillo.;Aaryan Kohli.;Saugat Khanal.;Nikola Ricchiuti.;Jaime DeSantiago.;Xiaoping Wan.;Mei Han.;Abigail Richardson.;Mei Yang.;Jesus Rondon.;Le Shen.;Jun Sun.;Qiangrong Liang.;Thomas J Hund.;Jaroslaw Meller.;Isabelle Deschenes.;Dan J Bare.;Xun Ai.
来源: Circulation. 2026年153卷25期2029-2043页
Atrial fibrillation (AF) is the most common arrhythmia and is associated with high morbidity and mortality, particularly in the aging population. Current treatment and prevention strategies remain suboptimal, highlighting the urgent need to better understand the mechanisms underlying aging-associated AF. We recently reported a causal role of the stress-activated kinase JNK2 (c-Jun N-terminal kinase 2) in aging-associated AF pathogenesis, mediated by JNK2-driven sarcoplasmic reticulum Ca2+ dysfunction. However, the mechanisms by which cardiac JNK2 is activated during aging to promote AF remain unclear. Emerging evidence suggests that interorgan crosstalk contributes critically to the development of cardiovascular diseases. A hyperpermeable gastrointestinal epithelial barrier ("leaky gut"), commonly observed in aged individuals, is associated with elevated levels of proinflammatory cytokines and an increased risk of AF. Although proinflammatory cytokines have been proposed as predisposing factors for AF, clinical and experimental studies have yielded inconsistent results, underscoring the complexity of inflammation-associated AF pathogenesis. Here, we investigated whether cardiac JNK2 integrates diverse stress stimuli, including proinflammatory cytokines and lipopolysaccharide, to drive AF pathogenesis.
427. Quantitative Vector Screening to Improve Sensing and Reduce Inappropriate Shocks With the Subcutaneous Implantable Cardioverter Defibrillator.
作者: Thomas A Boyle.;David C Callans.;Rajat Deo.;Sanjay Dixit.;Andres Enriquez.;Andrew E Epstein.;Fermin Garcia.;Gustavo Guandalini.;Balaram K Hanumanthu.;Matthew C Hyman.;Ramanan Kumareswaran.;David Lin.;Francis E Marchlinski.;Timothy M Markman.;Maiwand Mirwais.;Saman Nazarian.;Michael Riley.;Vincent See.;Poojita Shivamurthy.;Gregory E Supple.;Robert Schaller.;David S Frankel.
来源: Circ Arrhythm Electrophysiol. 2026年19卷5期e014581页
The subcutaneous implantable cardioverter defibrillator (S-ICD) offers protection from sudden cardiac death without transvenous leads. Although contemporary techniques and programming have reduced inappropriate shocks, high rates persist in certain populations. The objective of this study was to evaluate the impact of a novel quantitative vector screening (QVS) protocol on the incidence of sensing-related complications and inappropriate shocks in patients undergoing S-ICD implantation.
428. WNT5a-Mediated Aberrant Actin Filament Dynamics Drive Cardiac Pathogenic Phenotypes in LMNA-Related Emery-Dreifuss Muscular Dystrophy.
作者: Hangping Fan.;Xiaochen Wang.;Xujie Liu.;Jiuxiao Zhao.;Yuan Zhang.;Zongkuai Yang.;Hao Wang.;Junhao Gong.;Lingying Li.;Jiamin Jin.;Yuxuan Guo.;Tingyu Gong.;Lenan Zhuang.;Qing Ke.;Ping Liang.
来源: Circulation. 2026年153卷22期1719-1742页
Emery-Dreifuss muscular dystrophy (EDMD) is a rare genetic disorder characterized by early-onset joint contractures, progressive muscle atrophy, and cardiac abnormalities. Patients with EDMD carrying LMNA sequence variations often exhibit severe cardiac manifestations, including frequent atrioventricular block and ventricular tachycardia. Approximately 20% of those patients may ultimately require heart transplantation. The molecular mechanisms by which LMNA sequence variations lead to EDMD remain unknown.
429. Targeting E3 Ubiquitin Ligase Hrd1 Prevents Myocardial Ischemia-Reperfusion Injury Through Enhancing ALDH2 Enzymatic Activity.
作者: Shuolin Liu.;Chuanyin Li.;Min Zhu.;Tingfang Zhu.;Yiran E Li.;Yanlin Liu.;Chenguo Xu.;Hongyan Wang.;Ronggui Hu.;Junbo Ge.;Yingmei Zhang.
来源: Circulation. 2026年154卷4期334-353页
Myocardial ischemia-reperfusion (I/R) injury presents a significant clinical challenge characterized by a complex pathological mechanism. The role of protein ubiquitination in I/R injury has not been systematically investigated. Global ubiquitinome profiling was conducted to identify the potential key players in myocardial I/R injury.
430. The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.
作者: Robert Przybylski.;Gabrielle Norrish.;Brian Claggett.;Euan A Ashley.;Vinay Bhole.;Sharlene M Day.;Grazia Delle Donne.;Adrian Fernandez.;Francesca Girolami.;Belinda Gray.;Adam S Helms.;Jodie Ingles.;Peter Kubus.;Neal K Lakdawala.;Rachel J Lampert.;Kimberly Y Lin.;Michelle Michels.;Erin Miller.;Iacopo Olivotto.;Anjali Owens.;Victoria N Parikh.;Silvia Passantino.;Cristina Ramona Radulescu.;Joseph Rossano.;Mark W Russell.;Thomas D Ryan.;Sara Saberi.;Georgia Spentzou.;John C Stendahl.;James S Ware.;Robert G Weintraub.;Lidia Ziolkowska.;Peter-Paul Zwetsloot.;Juan Pablo Kaski.;Carolyn Y Ho.;Dominic J Abrams.; .
来源: Circulation. 2026年153卷19期1463-1476页
Massive left ventricular hypertrophy (LVH) is a risk factor for sudden cardiac death in children with hypertrophic cardiomyopathy (HCM), but little is understood about its natural history.
431. Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.
作者: Jakob Fell.;Mario Pavez-Giani.;Fabian Koitka.;George Kensah.;Gabriela Leao Santos.;Emiel P C van der Vorst.;Christof Lenz.;Gabriela Salinas.;Alexandra Victoria Busley.;Alisa Fedorenko.;Robin Hindmarsh.;Cordula Maria Wolf.;Susanne Lutz.;Gerd Hasenfuss.;Wolfram-Hubertus Zimmermann.;Bernd Wollnik.;Lukas Cyganek.
来源: Circulation. 2026年
Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome (NS). Despite paracrine communication being considered to play a pivotal role in the etiology of cardiomyopathies, there is a paucity of knowledge about the underlying pathomechanism that leads to the development of hypertrophic cardiomyopathy and cardiac fibrosis in NS.
432. Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry.
作者: Bhavanadhar Penta.;Gilbert H L Tang.;Mohamed Abdel-Wahab.;Rik Adrichem.;Hasan Ahmad.;Martin Andreas.;Anita W Asgar.;Igor Belluschi.;Walid Ben-Ali.;Oliver D Bhadra.;Anson Cheung.;Andrea Colli.;Lenard Conradi.;Silvia Corona.;Ole De Backer.;Paolo Denti.;Nimesh D Desai.;Marco Di Eusanio.;J Michael DiMaio.;John K Forrest.;Shinichi Fukuhara.;Arnar Geirsson.;Sachin S Goel.;Joshua B Goldberg.;Christian Hagl.;Howard C Herrmann.;Thijmen W Hokken.;Jorg Kempfert.;Philipp Kiefer.;Neal S Kleiman.;Chad Kliger.;Markus Mach.;Mateo Marin-Cuartas.;David Meier.;Thomas Modine.;George Petrossian.;Luigi Pirelli.;Basel Ramlawi.;Newell B Robinson.;Joshua D Rovin.;Hendrik Ruge.;Shekhar Saha.;Christian C Schults.;Emily Shih.;Molly Szerlip.;Maurizio Taramasso.;Axel Unbehaun.;Nicolas M Van Mieghem.;Keti Vitanova.;Ron Waksman.;Lin Wang.;John G Webb.;Moritz C Wyler von Ballmoos.;Michael J Reardon.;Tamim N Nazif.;Martin B Leon.;Michael J Mack.;Tsuyoshi Kaneko.;Vinayak N Bapat.;Syed Zaid.; .
来源: Circ Cardiovasc Interv. 2026年19卷6期e016068页
As transcatheter aortic valve replacement (TAVR) expands to patients with longer life expectancy, the impact of failure mechanisms on outcomes of TAVR-explant and redo-TAVR remains uncertain. We sought to evaluate outcomes of TAVR reintervention based on the failure mechanism of the index transcatheter aortic valve.
435. Targeting PPAR-γ Reduces Fibrosis and Arrhythmogenic Remodeling in DSG2-Linked Arrhythmogenic Cardiomyopathy.
作者: Yung-Hsin Yeh.;Yu-Shien Ko.;Yi-Hsin Chan.;Ying-Ju Lai.;Gwo-Jyh Chang.;Chi-Jen Chang.;Lung-An Hsu.
来源: Circ Genom Precis Med. 2026年19卷3期e005434页
Arrhythmogenic cardiomyopathy is an inherited disorder characterized by fibro-fatty myocardial replacement and ventricular arrhythmias. Although desmosomal mutations such as desmoglein-2 (DSG2) are well-established causes, the pathogenic mechanisms of specific missense variants remain incompletely defined.
437. Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis.
作者: Emanuele Monda.;Sabrina Montuoro.;Lia Crotti.;Cristina Basso.;Martina Caiazza.;Emanuele Bobbio.;Camillo Autore.;Elena Arbelo.;Gaetano Diana.;Perry Mark Elliott.;Eloisa Arbustini.;Giuseppe Limongelli.
来源: Circ Genom Precis Med. 2026年19卷3期e005523页
Sudden arrhythmic death syndrome (SADS) refers to sudden cardiac death with structurally normal hearts at autopsy, most frequently attributed to inherited arrhythmia syndromes or concealed cardiomyopathies. Postmortem genetic testing may help identify underlying genetic causes. We aimed to investigate the yield of postmortem genetic testing in SADS cases by determining the prevalence of pathogenic or likely pathogenic variants in channelopathy- and cardiomyopathy-associated genes in autopsy-negative SADS victims.
438. FGF12 Alleviates Cardiac Hypertrophy by Inhibiting Phosphorylation of CaM/CaMKII/CREB1 Axis.
作者: Taojun Zhang.;Kunlun Yin.;Tianjiao Li.;Shuiyun Wang.;Zhou Zhou.
来源: Circ Genom Precis Med. 2026年19卷3期e005362页
Hypertrophic cardiomyopathy (HCM) arises from genetic mutations in sarcomere proteins, resulting in major structural abnormalities and limited treatment options. Patients with HCM had reduced expression of the FGF12 (fibroblast growth factor 12), but its precise functional role remains unclear.
439. RACGAP1 as a Circulating Biomarker of Atrial Fibrillation in Heart Failure: A Dual-Cohort Proteomic Study.
作者: Amen Bekele Zelleke.;Joe David Azzo.;Jonathan D Moreno.;Douglas L Mann.;Thomas P Cappola.;Julio A Chirinos.;Ali Javaheri.
来源: Circ Arrhythm Electrophysiol. 2026年19卷5期e014024页 440. Automated Cardiac Arrest Detection Using Wrist-Worn Photoplethysmography: External Validation in Patients With Induced Shockable Cardiac Arrest (DETECT-1b).
作者: Roos Edgar.;Niels T B Scholte.;Kambiz Ebrahimkheil.;Catharina E Jansen.;Rypko J Beukema.;Marc A Brouwer.;Sing-Chien Yap.;Masih Mafi-Rad.;Reinoud E Knops.;Eelko Ronner.;Aysun Cetinyurek-Yavuz.;Kevin Vernooy.;Eric Boersma.;Peter C Stas.;Niels van Royen.;Judith L Bonnes.
来源: Circ Arrhythm Electrophysiol. 2026年19卷5期e014708页 |